Chronic Lymphoproliferative Disorder Panel (CD5, CD10, CD19, CD20, CD22, CD23, CD25, CD38, CD11c, CD103, FMC7, HLA DR, Surface Immunoglobulins and Light Chains)

This is a flow cytometry test that can be performed using blood, bone marrow aspirate, or body fluids. In addition to standard
B-cell and T-cell markers, it includes CD38 and FMC7, which assist in the differential diagnosis of other B-cell lymphoproliferative disorders. Chronic lymphoproliferative disorder can have widely variable outcomes. Immunophenotypic markers can help identify patients with a higher risk for aggressive disease and will be helpful in devising management strategy.